Updates of perioperative multidisciplinary treatment for surgically resectable esophageal cancer.

Tsuji, Takayuki; Matsuda, Satoru; Takeuchi, Masashi; Kawakubo, Hirofumi; Kitagawa, Yuko

Tsuji, Takayuki; Matsuda, Satoru; Takeuchi, Masashi; Kawakubo, Hirofumi; Kitagawa, Yuko.

Affiliation

Tsuji T; Department of Surgery, Keio University School of Medicine Tokyo, Japan.
Matsuda S; Department of Surgery, Keio University School of Medicine Tokyo, Japan.
Takeuchi M; Department of Surgery, Keio University School of Medicine Tokyo, Japan.
Kawakubo H; Department of Surgery, Keio University School of Medicine Tokyo, Japan.
Kitagawa Y; Department of Surgery, Keio University School of Medicine Tokyo, Japan.

Jpn J Clin Oncol ; 53(8): 645-652, 2023 Jul 31.

Article in En | MEDLINE | ID: mdl-37282626

Subject(s)

Esophageal Neoplasms; Fluorouracil; Humans; Fluorouracil/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Esophageal Neoplasms/drug therapy; Cisplatin/therapeutic use; Prognosis; Neoadjuvant Therapy/methods

Key words

adjuvant treatment; clinical trial; esophageal cancer; multidisciplinary treatment; neoadjuvant treatment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Fluorouracil Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Jpn J Clin Oncol Year: 2023 Document type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google